KRENSAVAGE ASSET MANAGEMENT, LLC – Regeneron Pharmaceuticals, Inc. Transaction History
KRENSAVAGE ASSET MANAGEMENT, LLC portfolio value:
$41.94M
portfolio value
KRENSAVAGE ASSET MANAGEMENT, LLC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.84% | 505 shares | 6.25M | $688.87 | 60.88K |
| Q2 2022 | share | Decrease | -9.71% | -6.49K shares | -11.01M | $591.13 | 60.38K |
| Q1 2022 | share | Decrease | -3.18% | -2.2K shares | 3.08M | $698.42 | 66.88K |
| Q4 2021 | share | Decrease | -5.55% | -4.06K shares | -640K | $642.51 | 69.08K |
| Q3 2021 | share | Decrease | -10.91% | -8.96K shares | -1.59M | $605.18 | 73.14K |
| Q2 2021 | share | Decrease | -0.72% | -594 shares | 6.73M | $558.54 | 82.10K |
| Q1 2021 | share | Increase | +0.61% | 498 shares | -584K | $473.14 | 82.69K |
| Q4 2020 | share | Decrease | -0.07% | -58 shares | -6.33M | $483.11 | 82.2K |
| Q3 2020 | share | Increase | +3.22% | 2.56K shares | -3.65M | $559.78 | 82.25K |
| Q2 2020 | share | Decrease | -8.21% | -7.12K shares | 7.30M | $623.65 | 79.69K |
| Q1 2020 | share | Decrease | -16.86% | -17.60K shares | 3.18M | $488.29 | 86.81K |
| Q4 2019 | share | Increase | 0.00% | 104.42K shares | 39.20M | $375.48 | 104.42K |